These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23971642)

  • 1. Endothelial dysfunction and angiogenesis in autosomal dominant polycystic kidney disease.
    Fick-Brosnahan GM
    Curr Hypertens Rev; 2013 Feb; 9(1):32-6. PubMed ID: 23971642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in autosomal-dominant polycystic kidney disease.
    Bello-Reuss E; Holubec K; Rajaraman S
    Kidney Int; 2001 Jul; 60(1):37-45. PubMed ID: 11422734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease.
    Theodorakopoulou M; Raptis V; Loutradis C; Sarafidis P
    Semin Nephrol; 2019 Nov; 39(6):599-612. PubMed ID: 31836042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.
    Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Lampropoulou I; Intzevidou E; Sioulis A; Balaskas E; Sarafidis PA
    Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Wang W; Farmer-Bailey H; Gitomer B; Malaczewski M; Klawitter J; Jovanovich A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1493-1501. PubMed ID: 30228110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease.
    Wang D; Iversen J; Wilcox CS; Strandgaard S
    Kidney Int; 2003 Oct; 64(4):1381-8. PubMed ID: 12969157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function.
    Gul CB; Yildiz A; Sag S; Oruc A; Ersoy A; Gullulu S
    Ren Fail; 2021 Dec; 43(1):1124-1129. PubMed ID: 34256663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?
    Andries A; Daenen K; Jouret F; Bammens B; Mekahli D; Van Schepdael A
    Pediatr Nephrol; 2019 Jun; 34(6):993-1008. PubMed ID: 30105413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial.
    Nowak KL; Farmer-Bailey H; Wang W; You Z; Steele C; Cadnapaphornchai MA; Klawitter J; Patel N; George D; Jovanovich A; Soranno DE; Gitomer B; Chonchol M
    Clin J Am Soc Nephrol; 2022 Feb; 17(2):240-250. PubMed ID: 34907021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Nat Rev Nephrol; 2009 Apr; 5(4):221-8. PubMed ID: 19322187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
    Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis and autosomal dominant polycystic kidney disease.
    Huang JL; Woolf AS; Long DA
    Pediatr Nephrol; 2013 Sep; 28(9):1749-55. PubMed ID: 22990303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.
    Nowak KL; Gitomer B; Farmer-Bailey H; Wang W; Malaczewski M; Klawitter J; You Z; George D; Patel N; Jovanovich A; Chonchol M
    Am J Kidney Dis; 2019 Aug; 74(2):213-223. PubMed ID: 30803706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F; Williams O; Chapman A
    Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cyst cytokines promote endothelial cell proliferation and development.
    Brodsky KS; McWilliams RR; Amura CR; Barry NP; Doctor RB
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1155-65. PubMed ID: 19596832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.
    Nowak KL; Farmer H; Cadnapaphornchai MA; Gitomer B; Chonchol M
    Nephrol Dial Transplant; 2017 Feb; 32(2):342-347. PubMed ID: 28186577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Yilmaz MI; Orscelik O; Sipahioglu MH; Unal A; Eroglu E; Kalay N; Tokgoz B; Axelsson J; Oymak O
    Nephron Clin Pract; 2013; 123(3-4):157-64. PubMed ID: 23887359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
    Lai S; Mittherhofer AP; Cianci R; Riviello L; Vocaturi M; Mastroluca D; Ciccariello M; Von Heland M; Ricciuti GP; Salciccia S; Mazzaferro S
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.